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Background-—Hypertension is the major risk factor for cardiovascular disease, the most common cause of death worldwide.
Resistance arteries are capable of adapting their diameter independently in response to pressure and flow-associated shear stress.
Ryanodine receptors (RyRs) are major Ca2+-release channels in the sarcoplasmic reticulum membrane of myocytes that contribute
to the regulation of contractility. Vascular smooth muscle cells exhibit 3 different RyR isoforms (RyR1, RyR2, and RyR3), but the
impact of individual RyR isoforms on adaptive vascular responses is largely unknown. Herein, we generated tamoxifen-inducible
smooth muscle cell–specific RyR2-deficient mice and tested the hypothesis that vascular smooth muscle cell RyR2s play a specific
role in elementary Ca2+ signaling and adaptive vascular responses to vascular pressure and/or flow.
Methods and Results-—Targeted deletion of the Ryr2 gene resulted in a complete loss of sarcoplasmic reticulum–mediated Ca2+-
release events and associated Ca2+-activated, large-conductance K+ channel currents in peripheral arteries, leading to increased
myogenic tone and systemic blood pressure. In the absence of RyR2, the pulmonary artery pressure response to sustained hypoxia
was enhanced, but flow-dependent effects, including blood flow recovery in ischemic hind limbs, were unaffected.
Conclusions-—Our results establish that RyR2-mediated Ca2+-release events in VSCMs specifically regulate myogenic tone
(systemic circulation) and arterial adaptation in response to changes in pressure (hypoxic lung model), but not flow. They further
suggest that vascular smooth muscle cell–expressed RyR2 deserves scrutiny as a therapeutic target for the treatment of vascular
responses in hypertension and chronic vascular diseases. ( J Am Heart Assoc. 2019;8:e010090. DOI: 10.1161/JAHA.118.
010090.)
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A rteries adapt to hemodynamic forces through changes intheir diameter. These adaptive responses take 2 forms
that reflect the operation of 2 independent mechanisms: (1) a
decrease in vessel diameter in response to increased
transmural pressure, a response termed myogenic constric-
tion (or Bayliss effect) that is intrinsic to smooth muscle (SM)
myocytes; and (2) an increase in vessel diameter in response
to increased blood flow, reflecting the short- and long-term
action of shear stress on the vessel wall, the latter of which
reflects outward remodeling of the vascular SM cell (VSMC)
layers.1
In arterial SM cells (SMCs), membrane depolarization
produces a moderate (100–300 nmol/L) increase in intracel-
lular Ca2+ concentration ([Ca2+]i) because of influx of Ca
2+
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ions through the voltage-dependent L-type Ca2+ channel,
CaV1.2.
2 This increase in global Ca2+ causes myocyte
contraction through activation of Ca2+-dependent myosin
light chain kinase and induction of myosin-actin cross-bridge
cycling.3 An additional important contributor to the contrac-
tility of VSMCs is the ryanodine receptor (RyR), an ion channel
in the sarcoplasmic reticulum (SR) that mediates Ca2+ release,
detected optically as “Ca2+ sparks.” Ca2+ sparks are elemen-
tary Ca2+-release events generated by a single Ca2+-release
unit composed of a cluster of RyRs in the SR.4,5 Unlike Ca2+
influx via voltage-dependent L-type Ca2+ channels, Ca2+
release from the SR in the form of Ca2+ sparks paradoxically
causes vasodilation.6,7 There are 2 reasons for this counter-
intuitive effect of Ca2+ sparks. First, a single spark is capable
of producing a high (10–100 lmol/L) local (1% of the cell
volume) increase in [Ca2+]i,
8,9 but increases global [Ca2+]i by
<2 nmol/L.6,10 Second, Ca2+ sparks occur in close proximity
to the cell membrane, where every Ca2+ spark activates
numerous large-conductance Ca2+-sensitive K+ (BKCa) chan-
nels, causing K+ efflux.8,11–13 The resultant “spontaneous
transient outward currents” (STOCs) cause hyperpolarization
of the cell membrane, thereby shutting off tonic Ca2+ entry
through Cav1.2 channels through channel deactivation.
Therefore, the net result of Ca2+ spark–BKCa channel coupling
is decreased global [Ca2+]i and vasorelaxation.
6,11–15
The ability of RyRs to produce Ca2+ sparks in VSMCs may
depend on the RyR isoform. Mammals possess 3 subtypes of
RyRs (RyR1, RyR2, and RyR3), each composed of >5000
amino acids with a total molecular mass of 565 kDa.16–19
The 3 RyRs show 66% to 70% overall amino acid identity,20
and all 3 RyR isoforms are expressed in arterial SM.21,22
Coussin et al23 suggested that both RyR1 and RyR2 con-
tribute to spontaneous Ca2+ sparks in cultured VSMCs from
the portal vein, a suggestion supported by the observation
that antisense oligonucleotides against RyR3 had no effect on
spontaneous Ca2+ spark activity.24 Consistent with this, we
previously showed that the peak amplitude, width, and
duration of Ca2+ sparks in freshly isolated cerebral VSMCs
from RyR3-deficient (Ryr3/) mice were normal.25 However,
the frequency of Ca2+ sparks was higher in RyR3-deficient
VSMCs than in wild-type cells, suggesting that RyR3 might
play a role in modulating RyR1 and/or RyR2 function. A
specific role of RyR1 in SR Ca2+ release in pulmonary artery
VSMCs was suggested on the basis of the observation that
hypoxia-induced increases in [Ca2+]i and contraction were
largely eliminated in Ryr1+/- VSMCs.26 However, results from
global gene knockout mouse models are difficult to interpret
because of possible confounding effects of compensatory
mechanisms. In addition, the contributions of the RyR2
subtype to arterial elementary Ca2+ signaling and adaptive
responses in the vasculature remain unclear.
Herein, we established the first tamoxifen-inducible, SM-
specific RyR2-knockout (SM-Ryr2/) mouse model to test
the hypothesis that RyR2 contributes to SR Ca2+ release in
arterial VSMCs. Unexpectedly, we found that the RyR2
isoform plays a dominant role in local and global VSMC SR
Ca2+ release in both systemic and pulmonary arteries. We
further found that the expression of VSMC RyR2 is an
essential prerequisite for the formation of Ca2+ sparks, which
limit arterial myogenic constriction to pressure. Furthermore,
we found that RyR2 plays an important role in the pulmonary
artery pressure response to sustained hypoxia but does not
contribute to flow-induced increases in pulmonary arterial
pressure. Finally, RyR2 does not contribute to postischemic
recovery of blood flow in a hind limb occlusion model.
Methods
The data that support the findings of this study are available
from the corresponding author on reasonable request.
Mouse Model
Animal care followed American Physiological Society guide-
lines. All animal protocols were approved by the local animal
care committee (LAGeSo, Berlin, Germany) and the animal
welfare officers of the Max Delbr€uck Center for Molecular
Medicine. There are no ethical concerns. Mice were main-
tained in individually ventilated cages (IVC, Techniplast,
Germany) under standardized conditions with a 12-hour
dark-light cycle and free access to standard chow (0.25%
sodium; SSNIFF Spezialit€aten, Soest, Germany) and drinking
Clinical Perspective
What Is New?
• Our study demonstrates a specific contribution of ryanodine
receptor type 2 in mediating vascular smooth muscle cell
Ca2+-release events relevant for regulating myogenic tone in
the systemic circulation.
• We also found that ryanodine receptor type 2 provides a
negative regulatory role in hypoxic vasoconstriction in the
pulmonary circulation but does not contribute to postis-
chemic recovery of blood flow conductance in the hind limb
circulation.
What Are the Clinical Implications?
• These findings elucidate the role and mechanism of
ryanodine receptor type 2 channels in myogenic constric-
tion and in regulating adaptive reductions in arterial
diameter in response to pressure, but not flow.
• Our study potentially offers new possibilities for therapeutic
interventions in systemic and pulmonary hypertension.
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water. SM-Ryr2/ conditional knockout mice were created
by crossbreeding mice containing an Ryr2 gene containing a
loxP-flanked region (Figure 1A) (crrm1)27 with mice containing
tamoxifen-dependent Cre recombinase28 under the control of
the endogenous SM22a gene locus, which is selectively
expressed in SM of adult mice.29 The SMAKO mouse,2,30
carrying loxP-flanked CaV1.2 channel genes and the SM–
tamoxifen-dependent Cre recombinase knock-in transgene
(SM22a-CreT2),29 served as a source of the SM22a-CreT2 in
breeding experiments. The floxed variant of the Cav1.2
channel gene was eliminated after 2 generations of breeding,
resulting in the Ryr2flox/flox;SM22a-CreT2 mice used for
experiments. SM-Ryr2/ (Ryr2flox/flox;SM22a-CreT2 or
Ryr2flox/flox;SM22a-CreT2/T2) male mice (20–30 g, 8–
14 weeks old) and littermate or age-matched controls
(Ryr2+/+;SM22a-CreT2/T2, Ryr2+/+;SM22a-CreT2, Ryr2+/+,
Ryr2flox/+, or Ryr2flox/flox) were injected IP with tamoxifen
(30 lg/mg body weight) on 6 consecutive days. Mice showed
no gross anomalies before or after inducing Ryr2 gene
deletion in SM by tamoxifen treatment. Isolated arteries were
usually obtained after 2 to 3 days after tamoxifen treat-
ment. The SM myosin heavy chain–Cre31 line was from Stefan
Offermanns (Max-Planck-Institut f€ur Herz-und Lungen-
forschung, Bad Nauheim, Germany).
Western Blot Analysis
Thoracic aortae and hearts were isolated from mice and
placed into cold physiological saline solution (PSS) previously
oxygenated for 30 minutes (95% O2, 5% CO2). The composi-
tion of PSS (in mmol/L) was as follows: 119 NaCl, 4.7 KCl, 1.2
KH2PO4, 25 NaHCO3, 1.2 Mg2SO4, 11.1 glucose, and 1.6
CaCl2. Vessels were cleaned of perivascular fat, and all
tissues were immediately placed on dry ice and kept at
80°C until use. Samples were homogenized in radioim-
munoprecipitation assay buffer (Cell Signaling Technology,
Danvers, MA) containing protease inhibitors (Sigma-Aldrich,
Taufkirchen, Germany). Tubes containing homogenates were
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Figure 1. Conditional knockout of ryanodine receptor type 2 (RyR2) in vascular smooth muscle (SM) cells. A, Schematic representation of the
RyR2 wild-type (WT) allele, the allele containing loxP sequences (L2), and the floxed allele after the action of Cre recombinase (L1). B, Western
blot analysis of RyR2 protein in aortic and heart tissues from control and SM-Ryr2/ mice; 40 lg aortic tissue and 10 lg heart tissue were
loaded per lane. C, Immunohistochemical detection of WT (control) and SM-Ryr2/ aortae. Red indicates RyR2 staining; blue indicates stained
nuclei (4’,6-diamidino-2-phenylindole [DAPI]); green represents nonspecific autofluorescence. D, RyR1, RyR2, and RyR3 mRNA expression in
aortic tissue. RyR1/2/3 mRNA levels were normalized against 18s mRNA. Mean mRNA expression value was arbitrarily set at 1 for WT control
tissue, and relative expression was calculated for SM-Ryr2/ tissue (n=3 mice, RyR1 and RyR3 samples; n=6 mice, RyR2 WT; n=7 mice, RyR2
knockout). A.U. indicates arbitrary unit; SM-CreERT2, SM–tamoxifen-dependent Cre recombinase. *P<0.01 vs WT (unpaired t test).
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freeze thawed 3 times at 80°C and 37°C, respectively, and
then centrifuged at 9000g for 20 minutes at 4°C. After
determining the protein concentration, samples prepared in
Laemmli buffer (50 mmol/L Tris, pH 6.8, 10% SDS, 10%
glycerol, 5% mercaptoethanol, and 2 mg/mL bromophenol
blue) were boiled for 2 minutes, separated by SDS-PAGE on 7%
polyacrylamide gels, and transferred onto polyvinylidene fluo-
ride membranes. Membranes were blocked in 5% nonfat dry
milk in PBS containing 0.1% Tween 20, and then incubated
overnight at 4°C with primary anti-RyR2 antibody (catalog No.
MA3916, 1:800 final dilution; Pierce Biotechnology). After
washing, membranes were incubated with anti-mouse IgG-
peroxidase–linked secondary antibody (1:5000 final dilution;
GE Healthcare, UK) for 1 hour at room temperature. Blots were
washed and incubated in enhanced chemiluminescence
reagents (ECL Prime; Amersham Bioscience, UK), after which
bands were detected using a ChemiDoc XRS+ Imaging System
(Bio-Rad, Hercules, CA). An anti-GAPDH antibody (catalog No.
AM4300, 1:4000 final dilution; Ambion) was used as a loading
control, and Precision Plus Protein Prestained Standard (Bio-
Rad, Germany) was used as a molecular weight marker.
Immunohistochemistry
Isolated aortae were fixed in 4% formaldehyde solution for
1 hour on ice, after which they were incubated first in 3 mL of
50 mmol/L NH4Cl for 30 minutes on ice and then in 3 mL of
30% sucrose solution containing 2 mmol/L MgCl2 overnight
at 4°C. Fixed aortae were placed in Tissue-Tek and stored at
80°C. For immunohistochemistry, 5-lm cryosections of
aortae were incubated with rabbit polyclonal anti-RyR2
primary antibody (AB9080; Merck Millipore, Germany), diluted
1:500. Sections were incubated in 10% normal donkey serum
(Jackson ImmunoResearch Laboratories, Inc) for 30 minutes
to block nonspecific binding sites, and then incubated with
primary antibody for 1 hour at room temperature. All
incubations were performed in a humidified chamber. For
fluorescence visualization of bound primary antibody, sections
were further incubated with anti-rabbit Cy3-conjugated sec-
ondary antibody (Jackson ImmunoResearch Laboratories, Inc)
for 1 hour in a humidified chamber at room temperature.
Specimens were examined under a Zeiss Axioplan-2 imaging
microscope and analyzed with AxioVision 4.8 software (Zeiss)
by an investigator blinded to group-assignment information.
RNA Isolation and Quantitative Reverse
Transcription–Polymerase Chain Reaction
Total RNA was isolated from snap-frozen fat-free aortae using
the RNeasy RNA isolation kit (Qiagen). RNA concentration and
quality were measured using a NanoDrop-1000 spectropho-
tometer (PeqLab Biotechnologie, Germany). cDNA was
synthesized by reverse transcription from 2 lg of total RNA
(Applied Biosystems). Target mRNA expression levels were
analyzed by quantitative reverse transcription–polymerase
chain reaction using SYBR green reagents and an Applied
Biosystems 7500 Sequence Detector (Applied Biosystems).
Expression levels of the target Ryr2 gene, determined using
the relative standard curve method, were normalized to those
of 18s RNA. The following primer pairs were used: Ryr1, 50-
ATGACCGTAGGGCTCCTGGCCGTAG-30 (forward) and 50-GG
GTCCTCGATCTCGTCCCCGA-30 (reverse); Ryr2, 50-CTACCCG
AACCTCCAGCGATACT-30 (forward) and 50-GCAAAAGAAGG
AGATGATGGTGTG-30 (reverse); Ryr3, 50-ATTCTGACCAGCTC-
TTCCGC-30 (forward) and 50-TCTTCCGTTCCTGGTCCTGT-30
(reverse); and 18s RNA, 50-ACATCCAAGGAAGGCAGCAG-30
(forward) and 50-TTTTCGTCACTACCTCCCCG-30 (reverse).
Wire Myography
The thoracic aorta and mesenteric, tibial, femoral, and cerebral
arteries were removed immediately after euthanizing the mouse,
quickly transferred to cold (4°C), oxygenated (95% O2/5% CO2)
PSS (consisting of the following [in mmol/L]: 119 NaCl, 4.7 KCl,
1.2 KH2PO4, 25 NaHCO3, 1.2 Mg2SO4, 11.1 glucose, and 1.6
CaCl2), dissected into 2-mm rings, and trimmed of perivascular
fat and connective tissue. The composition of 60 mmol/L KCl
PSS (in mmol/L) was as follows: 63.7 NaCl, 60 KCl, 1.2 KH2PO4,
25 NaHCO3, 1.2Mg2SO4, 11.1 glucose, and 1.6 CaCl2. Each ring
was positioned between 2 stainless steel wires (diameter,
0.0394 or 0.025 mm) in a 5-mL organ bath of a Mulvany Small
Vessel Myograph (DMT 610 M; Danish Myo Technology,
Denmark) filled with PSS. The bath solution was continuously
oxygenated with a 95%O2/5% CO2 gasmixture and kept at 37°C
(pH 7.4). Aortic rings were placed under a tension of 0.3 g,32
whereas mesenteric, tibial, femoral, and cerebral rings were
placed under a tension equivalent to that generated at 0.9 times
the diameter of the vessel at 100 mm Hg. This normalization
procedure was performed to obtain the passive diameter of the
vessel at 100 mm Hg.32 Chart5 software (AD Instruments Ltd,
Spechbach, Germany) was used for data acquisition and display.
Rings were precontracted with 60 mmol/L KCl PSS and
equilibrated until a stable resting tension was attained. In some
experiments, vessels were treated sequentially with repeated
doses of 10 mmol/L caffeine at increasing time intervals (1, 2, 3,
4, and 5 minutes). Drugs were added to the bath solution unless
indicated otherwise. Tension is expressed as a percentage of the
steady-state tension (100%) obtained with isotonic external
60 mmol/L KCl.
Video Microscopic Ca2+ and Diameter Imaging
Ca2+ events in mesenteric arteries (third- and fourth-order
branches) were studied after loading with the Ca2+-binding
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fluorescent dye Fluo-4-AM (10 lmol/L) in the presence of
pluronic acid (2.5 lg/mL) in a solution consisting of the
following (in mmol/L): 134 NaCl, 6 KCl, 10 glucose, 1 MgCl2,
2 CaCl2, and 10 HEPES (pH 7.4). After loading, the tissue was
placed in a chamber specialized for Ca2+ imaging and
superfused with PSS at a rate of 1 to 2 mL/min at 37°C.
Images were collected with a Noran Oz laser-scanning
confocal microscope and Nikon 960 water-immersion (nu-
merical aperture, 1.2) fluorescence objectives with the aid of
software developed by Prairie Technologies (Middleton, WI).
Fluo-4 was excited with a krypton-argon laser at 488 nm, and
the emitted fluorescence was collected at >500 nm. Each file
was recorded for 30 to 60 seconds, and images were
collected at a rate of 53 images/s. Imaging fields were
1319131 lm (2569256 pixels).33 The diameter of pressur-
ized arteries was monitored, as previously described.34
Isolation of Arterial VSMCs
VSMCs from tibial and mesenteric arteries were isolated, as
described.12,14 Briefly, arteries were removed and quickly
transferred to cold (4°C), oxygenated (95% O2–5% CO2) PSS.
The arteries were then cleaned, cut into pieces, and incubated
for 50 minutes at 37°C in Ca2+-free Hank’s solution consist-
ing of the following (in mmol/L): 55 NaCl, 80 sodium
glutamate, 5.6 KCl, 2 MgCl2, 10 glucose, and 10 HEPES (pH
7.4 with NaOH) containing 1 mg/mL BSA (Sigma, Tauf-
kirchen, Germany), 0.5 mg/mL papain (Sigma), and 1.0 mg/
mL dithiothreitol. The segments were then placed in Hank’s
solution containing 1 mg/mL collagenase (types F and H;
ratio, 30% and 70%, respectively; Sigma) and 0.1 mmol/L
CaCl2 for 10 minutes at 37°C. After several washes in Ca
2+-
free Hank’s solution (containing 1 mg/mL BSA), single cells
were dispersed from artery segments by gently triturating.
Cells were then stored in the same solution at 4°C.
Ca2+ Sparks
VSMCs were seeded onto glass coverslips and incubated with
the Ca2+ indicators Fluo-3-AM or Fluo-4-AM (10 lmol/L) and
pluronic acid (0.005%, w/v) for 60 minutes on ice (in the
same bath solution used for patch-clamp measurements).30
After loading, the cells were washed with bath solution for at
least 10 minutes at room temperature. Single SMCs were
imaged (at 20–59 frames/s) using a Nipkow disc-based
UltraView LCI confocal scanner (Perkin Elmer, Waltham, MA)
linked to a fast digital camera. The confocal system was
mounted on an inverted Diaphot microscope with a 940 oil-
immersion objective (numerical aperture, 1.3; Nikon). Images
were obtained by illumination with an argon laser at 488 nm
and by recording all emitted light >515 nm. Ca2+ spark
analyses were performed off-line using the UltraView Imaging
Suite software (Perkin Elmer). Ca2+ sparks were defined as
local fractional fluorescence increases that were clearly above
the noise level. Ca2+ spark frequency was calculated as the
number of detected sparks divided by the total scan time.
Line-scan images were obtained with a Bio-Rad imaging
system (Munich, Germany) attached to a Nikon Diaphot
microscope25,35 by illumination with a krypton-argon laser at
488 nm and by recording all emitted light >500 nm.
Electrophysiology
K+ currents were measured in the conventional whole-cell
configuration of the patch-clamp technique at room temper-
ature, as previously described.30,36 Patch pipettes (resistance,
3–5 MΩ) were filled with a solution containing the following
(in mmol/L): 110 K-Aspartate, 30 KCl, 10 NaCl, 1 MgCl2, and
0.05 EGTA (pH 7.2). For measurement of K+ currents in the
whole-cell perforated-patch mode, the patch pipette solution
was supplemented with 200 lg/mL amphotericin B, dis-
solved in dimethyl sulfoxide. The external bath solution
contained the following (in mmol/L): 134 NaCl, 6 KCl, 1
MgCl2, 2 CaCl2, 10 glucose, and 10 HEPES (pH 7.4). The
holding potential was 60 mV. Whole-cell currents were
recorded using an Axopatch 200B (Axon Instruments/Molec-
ular Devices, Sunnyvale, CA) or EPC 7 (List, Darmstadt,
Germany) amplifier and digitized at 5 kHz using a Digidata
1440A digitizer (Axon CNS, Molecular Devices) and pClamp
software versions 10.1 and 10.2. STOC analysis was
performed off-line using IGOR Pro (WaveMetrics, Lake
Oswego, OR) and Excel (Microsoft Corporation, Redmond,
WA).
Telemetry
Radiotelemetric blood pressure measurements were per-
formed on adult C57Bl6 SM-Ryr2/ mice, as described
elsewhere.37 After implanting blood pressure devices, mice
were allowed 2 weeks to recover from surgery and exhibit
regular diurnal activity rhythms. Targeted deletion of Ryr2 was
induced by administration of tamoxifen (see above).
Femoral Artery Occlusion Model and Assessment
of Blood Flow by Laser Doppler Imaging
Occlusion of the right femoral artery in 12-week-old mice was
performed, as described previously.38 For repetitive assess-
ment of hind limb blood flow after occlusion, we used the
noninvasive laser Doppler imaging technique.38 The laser
Doppler imaging technique depends on the Doppler principle,
whereby low-power light from a monochromatic stable laser
(wavelength, 830 nm; laser diode; model LDI2-HR; Moor
Instruments, UK), incident on tissue, is scattered by moving
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red blood cells, photodetected, and processed to provide a
measurement of blood flow. Artery structure of right and left
hind limbs was characterized after polyurethane treatment.39
Hypoxic and Caffeine-Induced Pulmonary
Vasoconstriction in Isolated Perfused and
Ventilated Mouse Lungs
Lungs were prepared, as described previously.40 Briefly, lungs
were perfused with 37°C sterile Krebs-Henseleit hydroxyethyl
amylopectin buffer (1 mL/min; Serag-Wiesner, Naila, Germany)
containing indomethacin (30 lmol/L; Sigma) and Nx-nitro-L-
arginine methyl ester hydrochloride (1 mmol/L; Sigma) in a
nonrecirculating manner; left atrial pressure was adjusted to
2.2 cmH2O. After isolation, lungs were ventilated with negative
pressure in a closed chamber, volume controlled with a tidal
volume of 8 mL/kg body weight, an end-expiratory pressure
of 2 cm H2O, and a respiratory rate of 90 breaths/min.
Hyperinflation (24 cm H2O) was performed at 4-minute
intervals. Mean pulmonary arterial pressure was continuously
monitored, and the difference in mean pulmonary arterial
pressure was expressed in cm H2O. After an initial steady-state
period of 10 minutes, lungs were perfused at a flow rate of 0.5,
1, 1.5, and 2 mL/min for 30 seconds each to generate a 4-
point pressure-flow curve under normoxic conditions. Flow was
then set to 1 mL/min and, after another steady-state period of
4 minutes, mean pulmonary arterial pressure was recorded in
response to a change from normoxic to hypoxic (1% O2)
ventilation.41 Second and third pressure-flow curves were
generated during hypoxic pulmonary vasoconstriction phase 1
and phase 2, respectively. After 88 minutes of hypoxia,
normoxic ventilation was reestablished and, after another
steady-state period of 22 minutes, caffeine (10 mmol/L) was
administered to the perfusate for 2 minutes; this latter stepwas
repeated twice at 12-minute intervals.
Materials
Fluo-3-AM and Fluo-4-AM were purchased from Molecular
Probes (Eugene, OR), and A23187 was from AppliChem
(Darmstadt, Germany). The antibody against RyR2 was from
Millipore/Chemicon (Schwalbach/Ts, Germany). All salts and
other drugs were obtained from Sigma-Aldrich (Munich,
Deisenhofen, or Schnelldorf, Germany) or Merck (Darmstadt,
Germany). In cases in which dimethyl sulfoxide was used as a
solvent, the maximal dimethyl sulfoxide concentration after
application did not exceed 0.5%.
Statistical Analysis
Data are presented as meansSEM. Descriptive statistics
were calculated, and variables were examined for meeting
assumptions of normal distribution without skewness and
kurtosis by using quantile-quantile plot, Shapiro-Wilk test, or
D’Agostino and Pearson omnibus normality test, as appropri-
ate.42 Statistically significant differences in mean values were
determined by Student unpaired t test or one-way ANOVA.
The Mann-Whitney U test was performed for comparison of
dose-response curves. Statistical tests were performed using
GraphPad Prism (San Diego, CA), R (R Foundation for
Statistical Computing, Vienna, Austria), or Excel (Microsoft
Corporation). In the quantitative polymerase chain reaction
experiments, mean mRNA expression value was arbitrarily set
at 100% for wild-type control tissue, and relative expression
was calculated for SM-Ryr2/ tissue, as previously
described for small amounts of tissues.43 P<0.05 was
considered statistically significant.
Results
SM-Ryr2/ mice, generated by SMC-targeted deletion of the
Ryr2 gene by tamoxifen-dependent Cre recombinase under
the control of the endogenous SM22a gene locus (Figure 1A),
showed virtually no detectable RyR2 mRNA in aortic, mesen-
teric, and tibial artery tissues compared with control mice and
completely lacked RyR2 protein (Figure 1B through 1D,
Figure S1B and S1C).
RyR2s in Global SR Ca2+ Release in Peripheral
Arteries
We next studied the contribution of RyR2 to global SR Ca2+
release and arterial contraction. SR Ca2+ release was induced
by the pan RyR activator caffeine (10 mmol/L). As shown in
Figure 2A and 2B, caffeine induced strong contractions of the
aorta and mesenteric, femoral, tibial, and cerebral arteries of
control mice. In contrast, caffeine (10 mmol/L) was largely
ineffective in inducing contraction in any of these arteries
from SM-Ryr2/ mice (Figure 2A and 2B). These data
indicate that the RyR2 isoform is the predominant contributor
to SR Ca2+-release–induced contraction of peripheral arteries.
The role of RyR2 in VSMC Ca2+ release after refilling of SR
Ca2+ stores was next investigated using a protocol of
repeated caffeine applications at varying time intervals.
Mesenteric arteries from control mice showed normal
contractions in response to caffeine (10 mmol/L) after an
interval of 5 minutes between caffeine applications (Fig-
ure 2C), indicating that VSMC RyR-sensitive SR Ca2+ stores
are refilled within 5 minutes after SR Ca2+ depletion by this
RyR activator. In contrast, vessels originating from SM-Ryr2/
 mice showed weak contractions in response to caffeine at
all time intervals (Figure 2A and 2C). These results support
the interpretation that RyR2 is the major isoform in VSMCs
involved in RyR-dependent SR Ca2+ release. In keeping with
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Figure 2. Effects of caffeine on peripheral artery contraction. A, Original recordings of contractile force of
mesenteric arteries from wild-type (control) and smooth muscle (SM)–Ryr2/ mice. Addition of caffeine
(10 mmol/L) into the bath solution is indicated by arrows. B, Effects of caffeine on contractile force in
various arteries from wild-type mice (n=13 mesenteric arteries of 2 mice; n=4 femoral arteries of 2 mice;
n=22 tibial arteries of 3 mice; n=12 aortae of 2 mice; n=10 cerebral arteries of 5 mice) and SM-Ryr2/
mice (n=16 mesenteric arteries of 2 mice; n=6 femoral arteries of 3 mice; n=24 tibial arteries of 4 mice;
n=6 aortae and n=8 cerebral arteries of 5 mice). C, Contraction of mesenteric arteries with repeated
applications of caffeine (10 mmol/L) at different time intervals (n=13 control rings; n=16 rings).
D, Concentration-response curves for the contractile effects of phenylephrine in mesenteric arteries of
control and SM-Ryr2/ mice (n=24 rings). E, Contraction of mesenteric arteries in response to repeated
applications of phenylephrine (1 lmol/L) in a Ca2+-free bath solution (n=24 rings of 3 mice each in
C through E). There were no differences between control and SM-Ryr2/ rings. n.s. indicates not
significant. *P<0.05.
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this, caffeine (10 mmol/L) induced a prominent increase in
arterial wall [Ca2+]i in control mesenteric arteries (Figure 3,
upper), but not in SM-Ryr2/ mesenteric arteries (Figure 3,
lower), as measured by video microscopy using Fluo-4-AM–
loaded vessels. However, vascular contractions in response to
the a1-adrenergic receptor agonist phenylephrine were nor-
mal in SM-Ryr2/ arteries in both Ca2+-containing PSS
(Figure 2D) and Ca2+-free PSS (Figure 2E). These latter
results indicate that RyR2 deficiency does not affect
phenylephrine-induced contractions of VSMCs in mesenteric
arteries.
RyR2s in Local Ca2+ Release in VSMCs of
Peripheral Arteries
Ca2+ sparks are local, elementary Ca2+-release events medi-
ated by RyRs that activate nearby BKCa channels to oppose
arterial constriction to elevations in transmural pressure.
Using our SM-Ryr2/ mice in conjunction with Nipkow
spinning-disc confocal microscopy, we investigated the role of
RyR2 in the generation and properties of Ca2+ sparks.
Ca2+ sparks were readily detected in tibial artery SMCs
from wild-type mice, as shown in Figure 4A through 4C, which
depicts fluorescence images of a representative Fluo-4–
loaded cell. Two regions of interest (ROIs), denoted by yellow
circles a and b (Figure 4A), are highlighted; these correspond
to nonspark and spark sites, respectively, as shown in
Figure 4B. Continuous recordings of changes in fluorescence
intensity over time revealed recurring Ca2+ sparks in ROI b
(Figure 4C, highlighted in detail in the inset), but not in ROI a.
Figure 4C also shows that subsequent application of
10 mmol/L caffeine, which causes activation of RyRs and
release of SR Ca2+, induced a transient increase in global
[Ca2+], detectable in both ROIs. Shortly after the caffeine-
induced increase in global [Ca2+], Ca2+ sparks were no longer
detectable in ROI b, consistent with the fact that depletion of
SR Ca2+ by caffeine eliminates the Ca2+ gradient that drives
RyR-mediated SR Ca2+ release, causing Ca2+ sparks to
disappear. Notably, VSMCs from SM-Ryr2/ mice showed
little or no global [Ca2+]i transient in response to treatment
with 10 mmol/L caffeine (Figure 4D and 4G). Moreover,
although the majority (87%) of VSMCs from control mice
Figure 3. Changes in arterial wall intracellular Ca2+ concentration. Ca2+ fluorescence video
microscopy images of mesenteric arteries from wild-type (WT; upper) and smooth muscle (SM)–
Ryr2/ (lower) mice before (left) and after (right) application of caffeine.
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Figure 4. Ca2+-release events (Ca2+ sparks) in wild-type and smooth muscle (SM)–Ryr2/
vascular SM cells (VSMCs). A, Ca2+ fluorescence image of a Fluo-4–loaded wild-type (control) tibial
artery SMC.B, Ca2+ fluorescence image of the same cell as inA during the occurrence of a Ca2+ spark.
Two-dimensional imageswere recorded at a rate of 20/s.C, Time course of Ca2+fluorescence changes
in cellular regions of interest (ROIs) without sparks (ROI a, upper) and with sparks (ROI b, lower).
Presence of 10 mmol/L caffeine is indicated by horizontal lines. D, Time course of Ca2+ fluorescence
changes in a ROI (similar size as inA) of an SM-Ryr2/ VSMC in the absence and presence of caffeine
(10 mmol/L). E, Percentage of VSMCs with Ca2+ sparks. F, Ca2+ spark frequencies in n=15 wild-type
and n=11 SM-Ryr2/ VSMCs. G, Increases in peak Ca2+ fluorescence induced by 10 mmol/L
caffeine inwild-type (control) and SM-Ryr2/ VSMCs (n=14 cells and n=8 cells, respectively; 3mice).
F/F0, flurescence/background fluorescence. *P<0.05.
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exhibited Ca2+ sparks (n=15), with an average frequency of
0.590.10 Hz, Ca2+ sparks were undetectable in VSMCs
from SM-Ryr2/ mice (n=11) (Figure 4E and 4F). We
confirmed our results using another transgenic mouse line
in which Cre recombinase expression is driven by the SM
myosin heavy chain promoter.44 Reverse transcription–poly-
merase chain reaction showed that RyR2 mRNA was almost
undetectable in aortic tissue, as well as mesenteric and tibial
arteries, of SM myosin heavy chain–Ryr2/ mice compared
with control mice (Figure 5A); and tibial artery SMCs from
these mice lacked Ca2+ sparks (Figure 5B through 5H). By
contrast, Ca2+ sparks were present in 55.3% of VSMCs from
control mice (n=123), albeit at a reduced frequency
(0.060.01 Hz) compared with VSMCs from wild-type litter-
mates of SM-Ryr2/ mice (Figure 5F and 5G). Additional
experiments performed in SMCs from mesenteric arteries
showed that 28% of wild-type (control) cells exhibited Ca2+
sparks (n=127), whereas no Ca2+ sparks were observed in
VSMCs from SM-Ryr2/ mice (n=104) (Figure S2). Control
VSMCs also showed a strong increase in [Ca2+]i in response
to 10 mmol/L caffeine, but VSMCs from SM-Ryr2/ mice
were largely unresponsive (Figure S2).
Although our results indicate an essential role for RyR2 in
mediating Ca2+ release in the form of sparks in VSMCs, other
reports have suggested that SMCs also express RyR1 and
RyR3.21,22,45 Therefore, we used high-resolution, confocal line-
scan imaging of VSMCs to further confirm the role of RyR2 in
Ca2+ spark formation, measuring Ca2+ sparks in close proximity
to the cell surface.30 Figure 6A shows a confocal line-scan image
of 2 Ca2+ sparks in a representative tibial artery SMC isolated
from a control mouse. Ca2+ sparks occurred at a frequency of
0.460.10 Hz (n=52) in tibial SMCs from these mice (Fig-
ure 6B), but were essentially absent (frequency, 0.020.01 Hz;
n=42) in VSMCs from SM-Ryr2/ mice. Together, these data
demonstrate that RyR2s are indispensable for Ca2+ spark
generation in SMCs of tibial and mesenteric arteries.
RyR2-Dependent Ca2+ Sparks Induce STOCs
In isolated myocytes under voltage-clamp conditions, Ca2+
sparks activate a small number of proximate BKCa channels to
cause a transient outward current, traditionally referred to as
STOCs. STOCs were recorded in tibial artery SMCs from control
and SM-Ryr2/ mice using the patch-clamp technique (Fig-
ure 7). A peak amplitude>28 pAabove baseline, the criterion for
a STOC at a holding potential of -20 mV, is 3 times the BKCa
single-channel current based on a conductance of 150 pS.46
Figure 7A shows recordings from a control VSMC at40,20,
and 0 mV, demonstrating the presence of STOCs at 20 mV
andmorepositivemembranepotentials. In contrast, STOCswere
absent in VSMCs from SM-Ryr2/ mice (Figure 7B). At
20 mV, 48% of control cells (n=31) exhibited STOCs, whereas
no SM-Ryr2/ VSMCs (n=25) exhibited STOCs (Figure 7C).
STOCs in control cells exhibited a frequency of 0.440.14 Hz
(Figure 7D) and a mean amplitude of 26.56.0 pA at 20 mV
(Figure 7E). Caffeine (10 mmol/L) induced a strong outward
BKCa current in control VSMCs (Figure S3A) that is attributable to
an increase in global [Ca2+]i in the micromolar range,
47 followed
by suppression of STOCs because of severe SRCa2+ depletion. In
contrast, caffeine failed to induce BKCa currents in SM-Ryr2
/
VSMCs (Figure S3B). These findings support the idea that RyR2s
generate Ca2+ sparks in VSMCs, which, in turn, activate BKCa
channels to produce STOCs. Notably, the Ca2+ ionophore
A23187 (5 or 10 lmol/L) induced large outward BKCa currents
in both control and SM-Ryr2/ VSMCs, indicating that BKCa
channels are present and their Ca2+ sensitivity is preserved after
ablation of Ryr2 (Figure 8A and 8B).
RyR2s in the Myogenic Response of Peripheral
Arteries
We next tested the function of the RyR2 Ca2+ spark–BKCa
channel pathway in opposing vasoconstriction to elevated
transmural pressure (myogenic tone). Isolated mesenteric
arteries were pressurized to 80 mm Hg and allowed to
develop myogenic tone with a functional Ca2+ spark–BKCa
channel pathway34 (Figure 9). The viability of vessels was
confirmed by measuring the contractile response to a
depolarizing concentration of KCl (60 mmol/L). The degree
of myogenic tone in pressurized arteries was expressed
relative to maximum diameter, determined by exposure to
Ca2+-free external PSS.34 Inhibition of the Ca2+ spark–BKCa
channel pathway with the RyR inhibitor ryanodine (10 lmol/
L)48 increased myogenic constriction in wild-type (control)
arteries (Figure 9A), consistent with previous reports.6,49 In
contrast, ryanodine had almost no effect on the diameters of
arteries from SM-Ryr2/ mice (Figure 9B and 9C). These
results indicate that the Ca2+ spark–BKCa channel pathway in
VSMCs limits myogenic tone through RyR2s, without the
involvement of other RyR isoforms.
RyR2s in the Pulmonary Circulation
In the lung, alveolar hypoxia leads to constriction of upstream
pulmonary arterioles through retrograde signal transduction
via gap junctions.50 Using an ex vivo lung perfusion model, we
investigated the role of VSMC RyR2s in the pulmonary artery
pressure response to hypoxia. Basal mean pulmonary arterial
pressure was not significantly different between control
(10.30.2 cm H2O) and SM-Ryr2/ (11.00.3 cm H2O)
lungs. There was also no difference in pulmonary arterial
pressure between control and SM-Ryr2/ lungs during the
short-term phase of hypoxia (phase 1) (Figure 10A and 10B).
However, under sustained hypoxia (phase 2), the increase in
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mean pulmonary arterial pressure was more pronounced in
SM-Ryr2/ lungs than in control lungs (Figure 10A and 10B).
This difference was observed over a wide range of flow rates
(0.5–2.0 mL/min) (Figure 10C). Notably, flow-induced
increases in mean pulmonary arterial pressure did not differ
between the 2 groups under normoxic conditions or in the
short-term phase of hypoxic pulmonary vasoconstriction
(Figure 10C). These results argue for an important role of
VSMC RyR2s in the sustained phase of hypoxic pulmonary
vasoconstriction, but not in the short-term phase. It is unlikely
that SR Ca2+ release through VSMC RyR1 or RyR3 plays an
important role in these effects because caffeine (10 mmol/L)
induced a transient pulmonary vasoconstriction in control
lungs, but not in SM-Ryr2/ lungs (Figure 10D and 10E).
RyR2s in the Ischemic Hind Limb Circulation
RyRs may play a role in postischemic recovery of blood flow
in the systemic peripheral circulation.51–53 In this setting, the
magnitude of collateral flow strongly depends on the shear-
stress–induced outward remodeling response of preexisting
collateral arteries in the hind limb.54,55 To investigate the
role of RyR2 in hind limb blood flow recovery after ligation of
the femoral artery, we monitored perfusion of the right hind
limb using the laser Doppler imaging technique and
compared it with that in the intact left hind limb. There
was no difference in blood flow recovery in the right hind
limb in control compared with SM-Ryr2/ mice within
21 days after ligation (Figure 11). These results argue
against an important role of RyR2 in postischemic recovery
of blood flow. Changes in systemic blood pressure may mask
the role of the gene(s) of interest in these effects. However,
we found that tamoxifen induced only a 3– to 4–mm Hg
increase in mean arterial blood pressure in SM-Ryr2/ mice
(Figure 12).
Discussion
Resistance arteries exhibit adaptive changes in their diameter
in response to pressure and flow that are mediated by distinct
mechanisms.1 Increases in transluminal pressure trigger an
adaptive reduction in diameter. This myogenic response,
which serves to normalize perfusion, is triggered by stretch-
sensitive mechanisms that operate in VSMCs.34 In contrast,
increases in blood flow act via an increase in shear stress to
trigger an increase in arterial diameter. Short-term increases
in blood flow/shear stress result in arterial dilation through a
mechanism that involves the endothelial-dependent NO
pathway, whereas long-term exposure to elevated shear
stress causes a structural increase in the arterial lumen. This
adaptive response requires activation of matrix metallopro-
teases that allow remodeling of the SM layers. In the current
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Figure 6. Line-scan imaging of Ca2+-release
events (Ca2+ sparks) in wild-type and smooth
muscle (SM)–Ryr2/ vascular SM cells (SMCs).
A, Confocal line-scan image of a Fluo-3-AM–loaded
tibial artery wild-type (control) cell showing the time
course of Ca2+ sparks. The line-scan image duration
was 5 s, and each line was 4 ms. B, Ca2+ spark
frequency in tibial artery SMCs from control (n=52)
and SM-Ryr2/ (n=42) mice. *P<0.05.
Figure 5. Ca2+-release events (Ca2+ sparks) in wild-type and smooth muscle myosin heavy chain (SMMHC)–Ryr2/ tibial
artery smooth muscle cells (SMCs). A, Ryanodine receptor type 2 (RyR2) mRNA expression in aortic, mesenteric artery, and tibial
artery tissues. mRNA levels for RyR2 were normalized against 18s mRNA. The mean mRNA expression value was arbitrarily set at
100 for wild-type (control) tissue, and relative expression was calculated for SMMHC-RyR2/ tissue (n=4 each). P value is given vs
control (1-sample t test). B, Ca2+ fluorescence image of a Fluo-4-AM–loaded control vascular SMC (VSMC). C, Ca2+ fluorescence
image of the same cell as in A during the occurrence of a Ca2+ spark. Two-dimensional images were recorded at a rate of 5/s. D,
Time course of Ca2+ fluorescence changes in cellular regions of interest (ROIs) without sparks (ROI a, left) and with sparks (ROI b,
right). E, Time course of Ca2+ fluorescence changes in an ROI (similar size as that in A) of an SMMHC-Ryr2/ VSMC. F,
Percentage of VSMCs with Ca2+ sparks. G, Ca2+ spark frequencies in VSMCs from control and SMMHC-Ryr2/ mice.
H, Amplitude of Ca2+ sparks (n=123 cells of 4 control mice; n=124 cells of 4 SMMHC-Ryr2/mice). A.U. indicates arbitrary unit.
F/F0, flurescence/background fluorescence. *P<0.05.
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study, we tested the contribution of VSMC RyR2s to
elementary Ca2+ signals and adaptive vascular responses to
pressure and flow.
RyR2s Mediate Elementary SR Ca2+ Events in
Arterial SMCs
Our results identify RyR2 as the key SR Ca2+-release channel
involved in generating Ca2+ sparks in VSMCs. In cardiac and
skeletal muscle, the intimate association between triggering
Cav1.x L-type channels and target RyRs is a prerequisite for
generating Ca2+ sparks from a single Ca2+-release unit.56–61
Although RyR2 plays a major role in Cav1.x/RyR coupling in
cardiac muscle,62 RyR1 is crucial in skeletal muscle.63,64
Although the importance of the Cav1.2 Ca
2+ channel for
proper function of arterial VSMCs is well established, we
previously demonstrated that Ca2+ spark generation in these
cells does not rely on the intimate association between
Cav1.2 L-type channels and RyRs.
30 Instead, Cav1.2 channels
contribute to global cytosolic [Ca2+], which, in turn, influ-
ences luminal SR Ca2+ and thus Ca2+ sparks.30 In the
present study, we investigated the contribution of RyR2s to
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Figure 7. Spontaneous transient outward currents (STOCs) caused by Ca2+-release events. A
and B, Original recordings of STOCs in tibial artery smooth muscle (SM) cells isolated from wild-
type (control) (A) and SM-Ryr2/ (B) mice. The holding potential was stepwise increased in 20-
mV increments from 40 to 0 mV. C through E, Comparison of STOC characteristics at 20 mV.
Percentage of cells with STOCs (C), STOC frequencies (D), and mean STOC amplitudes (E). n=31
cells of 11 control mice; n=25 cells of 9 SM-Ryr2/ mice. *P<0.05.
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Ca2+ sparks in arterial VSMCs. We found that RyR2s are
essential for the development of Ca2+ sparks/STOCs in
VSMCs and subsequent feedback regulation of myogenic
tone in response to transmural pressure. We further found
that RyR2s contribute to the pulmonary artery pressure
response to sustained hypoxia but have no effect on flow-
induced responses. Finally, we found that RyR2s do not
contribute to postischemic recovery of blood flow conduc-
tance in the peripheral systemic circulation, as shown in a
hind limb occlusion model.
VSMC RyR2s in Peripheral Arteries and Vascular
Adaptation to Pressure
Our data show that RyR2 is the major RyR isoform responsible
for Ca2+ sparks in the VSMC Ca2+-release unit of systemic
arteries. We reach this conclusion for several reasons. First,
Ca2+ sparks and STOCs were nearly abolished in SMCs of tibial
and mesenteric arteries obtained from SM-Ryr2/ mice,
suggesting an essential role for this RyR isoform in this process.
This result contrasts with the role of RyR1 in Ca2+ spark
generation in cultured VSMCs from portal veins, proposed by
Coussin and colleagues,23 who suggested that both RyR1 and
RyR2 contribute to spontaneous Ca2+ sparks. However, RyR
Ca2+ signaling pathways delineated in cultured cells may reflect
changes in protein expression that occur during cell dediffer-
entiation and may not represent a native feature of VSMCs.
The findings reported herein extend our previous studies on
Ryr3/ mice,25 in which we showed that the frequencies of
Ca2+ sparks and STOCs are increased in cerebral VSMCs from
Ryr3/ mice compared with those from wild-type mice. To
explain these results, we proposed that RyR3 acts as part of the
SR Ca2+-release unit to regulate the generation of Ca2+ sparks
by RyR1 and/or RyR2.25 In contrast to the effects of RyR3
ablation on frequency, Ca2+ spark and STOC amplitudes were
normal in Ryr3/ VSMCs, and caffeine induced normal global
Ca2+ release in Ryr3/ VSMCs. Second, we found that the pan
RyR activator caffeine failed to induce global SR Ca2+ release
and subsequent contraction of RyR2-deficient aortae and
femoral, tibial, mesenteric, cerebral, and pulmonary arteries.
These results indicate that RyR2 is the only RyR isoform in
VSMCs important for overall RyR-mediated SR Ca2+ release in
these vessels. This conclusion is supported by our finding that
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Figure 8. Functional large-conductance Ca2+-sensitive K+ chan-
nels in wild-type and smooth muscle (SM)–Ryr2/ vascular SM
cells (SMCs). A, Original current traces in wild-type (control) and
SM-Ryr2/ tibial artery SMCs before (control) and after
application of 5 or 10 lmol/L A23187. B, Summary of the
results (n=7 cells of 4 control mice; n=7 cells of 3 SM-Ryr2/
mice). I/I0, A23187-induced current/basal current. n.s. indicates
not significant.
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Figure 9. Arterial constriction induced by inhibition of Ca2+-
release events with ryanodine in wild-type and smooth muscle
(SM)–Ryr2/ peripheral arteries. A, Application of ryanodine
(10 lmol/L) provoked a strong constriction of isolated wild-type
(control) mesenteric arteries. B, Ryanodine-induced constriction
was reduced in SM-Ryr2/ arteries. C, Summary of the results
(n=6 cells of 4 control mice; n=6 cells of 5 SM-Ryr2/ mice).
The vertical gray and white bars in A and B represent the time
points for the analyzed myogenic tone values. *P<0.05.
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Figure 10. Function of ryanodine receptor type 2 (RyR2) in hypoxic pulmonary vasoconstriction. A,
Changes in mean pulmonary arterial pressure (DPpa mean) observed in isolated perfused and ventilated
lungs fromwild-type (control; closed squares, n=7mice) and smoothmuscle (SM)–Ryr2/ (open squares,
n=7 mice) mice after induction of hypoxic (1% O2) ventilation. B, Pulmonary pressure response (area under
the curve [AUC]) in control and SM-Ryr2/ lungs attributable to short-term (left, phase 1) and long-term
(right, phase 2) phases of hypoxic pulmonary vasoconstriction. C, Flow-induced Ppa increase in control
(closed symbols) and SM-Ryr2/ (open symbols) lungs under normoxia (squares), acute hypoxia
(triangles), and chronic hypoxia (circles). D, Pulmonary pressure response after application of caffeine
(10 mmol/L) in control (closed symbols) and SM-Ryr2/ (open symbols) lungs. Similar effects were
observed with 3 consecutive applications of caffeine. E, The peak increase in Ppa caused by the first
application of caffeine is shown. HPV, hypoxic pulmonary vasoconstriction; Q, flow rate. *P<0.05.
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repeated applications of caffeine failed to induce contractions
in mesenteric arteries of SM-Ryr2/ mice. Notably, vascular
contractions in response to the a1-adrenegic receptor agonist
phenylephrine were normal in SM-Ryr2/mesenteric arteries,
suggesting a lack of cross talk between RyR2s and IP3-sensitive
Ca2+ pools sensitive to inositol 1,4,5-trisphosphate (IP3) in the
SRof VSMCs, at least in these vessels. Third, an RyR2deficiency
caused a reduction in vascular relaxation through malfunction
of the Ca2+ spark–BKCa channel pathway. In these experiments,
application of the RyR inhibitor ryanodine constricted control
mesenteric arteries but caused almost no constriction of SM-
Ryr2/ mesenteric arteries. These findings cannot be
explained by a lack of functional BKCa channels in SM-Ryr2
/
VSMCs because our patch-clamp recordings showed normal
BKCa channel currents in these cells in response to 5 to
10 lmol/L A23187, which increases global [Ca2+]i to max-
imally activate BKCa channels.
47 Finally, systemic blood
pressure was increased in SM-Ryr2/ mice after genetic
ablation of Ryr2 in VSMCs. Although this increase was small
(3–4 mm Hg), it was statistically significant. Notably, such a
small difference is not surprising on the basis of experiments
using mice deficient in the BKCa b1 subunit, which exhibit
reduced functional coupling of Ca2+ sparks to BKCa channel
activation. In these experiments, targeted deletion of the
Kcnmb1 gene encoding the BKCa b1 subunit increased
systemic blood pressure by 10 mm Hg.11,12,65,66 Taken
together, these results strongly suggest that elementary SR
Ca2+ release in VSMCs is mainly driven by Ca2+ flux through
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Figure 11. Blood flow recovery after femoral artery ligation. A, Artery structure of right and left hind limbs
of a wild-type (control) mouse after polyurethane treatment. Left: Position of the femoral artery ligation is
marked by an arrow. B, Recovery of right hind limb perfusion after femoral artery ligation in control (n=4–
10) and smooth muscle (SM)–Ryr2/ (n=3–8) mice relative to the left hind limb perfusion. P≥0.05 for all
comparisons. Arrows mark native collateral arteries in the ligated and unligated hind limbs, revealing
outward remodeling of arteries after femoral artery ligation. Native collateral arteries refer to collaterals I
and II. Collateral III is newly developed within 1 to 3 weeks after the ligation.
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RyR2s. Accordingly, we suggest that RyR2s play a pivotal role
in the generation of Ca2+ sparks, which, in turn, activate BKCa
channels in VSMCs to limit arterial myogenic constriction in
response to transmural pressure. Our results indicate that other
RyR isoforms (RyR1 and RyR3) contribute minimally to phys-
iologically relevant Ca2+ sparks in VSMCs of systemic arteries.
VSMC RyR2s in Hypoxic Pulmonary
Vasoconstriction and Vascular Adaption to Flow
Using pharmacological tools, Du et al22 suggested that
RyRs exert an inhibitory regulatory role in the sustained
phase of hypoxic vasoconstriction in the pulmonary circu-
lation. Zheng et al67 attributed part of this hypoxic
pulmonary constriction to the action of RyR3, whereas Li
et al26 suggested a possible role for RyR1. However, both
groups used constitutive (ie, nonconditional) targeting of
RyRs, which might be associated with compensatory
developmental upregulation of other RyR isoforms. By
generating an inducible, SM-specific RyR2-knockout mouse
model, we were able to investigate RyR2 function in the
regulation of pulmonary arterial pressure and hypoxic
pulmonary vasoconstriction. In normoxia and in the short-term
phase of hypoxia, we found no differences in the pulmonary
arterial pressure response between control and SM-Ryr2/
lungs. However, our experiments revealed an important role of
VSMC RyR2s in the sustained phase of hypoxic pulmonary
vasoconstriction, although the molecular mechanisms are
mostly unclear. Oxidative stress and accumulation of cADP-
ribose and 15-lipoxygenase metabolites of arachidonic acid
(eg, 15-hydroxyeicosatetraenoic acid) have been implicated in
ryanodine-sensitive SR Ca2+ release in hypoxic pulmonary
constriction.68–71 Our results show that it is unlikely that SR
Ca2+ release through RyR1 or RyR3 plays an important role in
hypoxic pulmonary vasoconstriction because caffeine
(10 mmol/L) was unable to evoke contractile responses in
SM-Ryr2/ lungs. Although the BKCa channel itself is sensitive
to hypoxia,72 it is possible that this channel is involved in
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Figure 12. Mean arterial blood pressure (MAP) in smooth muscle (SM)–Ryr2/ mice. Time course of MAP (A), systolic blood pressure (SBP;
B), diastolic blood pressure (DBP; C), and heart rate (implantation of the telemetric sensor at day 0; D) in SM-Ryr2/ mice. E, Summary of the
results. MeanSEM values were calculated for time intervals before (days 6–14) and after (days 21–29) tamoxifen administration (n=6 mice).
Tamoxifen did not change these parameters in wild-type (WT; control) mice (DMAP, 0.8 mm Hg; DSBP, 1.2 mm Hg; DDBP, 0.0 mm Hg;
Dheart rate, 7.7 beats per minute [bpm]; no significant differences). F, MAP, SBP, and DBP did not change in WT mice before and after
administration of tamoxifen (n=6 mice each).
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hypoxic pulmonary vasoconstriction, because inhibition of BKCa
channels by charybdotoxin (50 ng/mL [10 nmol/L]) or
iberiotoxin (100 nmol/L) does not decrease hypoxic pul-
monary vasoconstriction, but instead enhances vasopressor
responses to ventilatory hypoxia in rats73 and rabbits.74 In
addition, mice lacking the BKCa b1 subunit show normal
pulmonary constriction to acute hypoxia.75 Future studies
should explore the mechanisms by which the RyR2 isoform
plays a protective role in sustained hypoxic pulmonary
vasoconstriction. Plasma membrane stretch-activated chan-
nels,76 TRPC1/6 channels (transient receptor potential
canonical channels),77–79 NADPH oxidase (nicotinamide
adenine dinucleotide phosphate oxidase),80 and cytochrome
P450–derived epoxyeicosatrienoic acids75 are promising
candidate molecules to investigate in this context.
VSMC RyR2s in Hind Limb Ischemia and Vascular
Adaptive Responses to Blood Flow
To test if RyR2s affect shear stress–induced responses, we
examined the remodeling of native hind limb collateral
arteries. It is well established that long-term increases in
shear stress trigger the opening and outward remodeling of
these preexisting bypasses.54,55 An increase in the size of
collateral arteries minimizes tissue injury and ischemia
caused by vaso-occlusive diseases, such as atherosclerosis.
Using the mouse hind limb femoral artery ligation model38,81
as an experimental model for monitoring collateral artery
recruitment, flow and remodeling characteristics, and tissue
ischemia in vivo, we found that SM-Ryr2/ mice and control
mice showed comparable blood flow characteristics. We also
observed a strong increase in collateral blood flow and
collateral diameter in both mouse strains in the short-term
phase as well as long-term (up to 3 weeks after occlusion).
This lack of differences in functional blood flow recovery
between the SM-Ryr2/ and wild-type scenario suggests
that, in this time period, RyR2 is not involved in adaptive
remodeling of the peripheral vasculature; it neither mediates
an acute dilation on changes in flow nor contributes to shear
stress–mediated changes in arterial structural properties.
Thus, although RyR2s have clear effects on VSMC Ca2+
sparks, shear-stress–induced remodeling in peripheral hind
limb ischemia appears normal in their absence. This is in
sharp contrast to mice that are presumed to have altered
Cav1.2 channel expression, which affects tonic Ca
2+ influx
into VSMCs.81 These mice exhibit an almost complete
absence of shear-stress–induced arterial remodeling and
collateral blood flow. Taken together, our data point toward
a specific contribution of RyR2s in mediating VSMC Ca2+
sparks that is relevant to the regulation of myogenic tone
(systemic circulation) and arterial remodeling in response to
changes in pressure (lung model), but not flow.
In conclusion, RyR2 is the predominant functional RyR
isoform involved in mediating Ca2+ sparks in VSMCs of mice.
We found that SM-specific genetic ablation of Ryr2 substantially
reduces Ca2+ sparks, which, in turn, prevents BKCa channel
activation, thereby increasing myogenic constriction. We
further established that VSMC RyR2s are important in regulat-
ing adaptive reductions in arterial diameter in response to
pressure, but not flow. We also found that RyR2 provides a
negative regulatory role in hypoxic vasoconstriction in the
pulmonary circulation but does not contribute to postischemic
recovery of blood flow conductance in the hind limb circulation.
Our study potentially offers new possibilities for therapeutic
interventions in systemic and pulmonary hypertension.
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Figure S1. Detection of RyR2 in hearts and different arteries of wild-type and SM-Ryr2-/- 
mice. 
 
 
A, Full-range Western blot of RyR2 in aortas from wild-type (control) and SM-Ryr2-/- mice; 40 
µg of aortic tissue and 10 µg of heart tissue were loaded per lane. B, mRNA expression for 
RyR1, RyR2, and RyR3 in mouse mesenteric artery tissue and C, for mouse tibial artery 
tissue. mRNA levels for RyR1/2/3 were normalized against 18s mRNA. Mean mRNA 
expression value was arbitrarily set at 100 for wild-type control tissue, and relative 
expression was calculated for SM-Ryr2-/- tissue (panel B: n = 3 vs. 2 arterial tissues each for  
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RyR1, n = 4 vs. 5 arterial tissues each for RyR2 and n = 2 vs. 2 arterial tissues each for 
RyR3 from n = 4 control mice and n = 5 SM-Ryr2-/- mice, respectively; panel C: n=4 vs. n=5 
arterial tissues (RyR1, RyR2, RyR3) each from n = 4 control mice and n = 5 SM-Ryr2-/- mice, 
respectively; *, p < 0.01 vs. wild-type; one-sample t-test). 
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Figure S2. Ca2+ sparks in wild-type and SM-Ryr2-/- mesenteric artery SMCs. 
 
 
 
 
A, Ca2+ fluorescence image of a Fluo-4-AM–loaded control VSMC. B, Ca2+ fluorescence 
image of the same cell as in A during the occurrence of a Ca2+ spark. Two-dimensional 
images were recorded at a rate of 10 s-1. C, Time course of Ca2+ fluorescence changes in 
cellular ROIs without sparks (ROI a, upper panel) and with sparks (ROI b, lower panel). Note 
that ROIs a and b are also labeled in panels A and B. Presence of caffeine (10 mmol/L) is 
indicated in by horizontal lines. D, Time course of Ca2+ fluorescence changes in a ROI 
(similar size as that in panel A) of a SM-Ryr2-/- VSMC in the absence and presence of 
caffeine (10 mmol/L). 
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Figure S3. BKCa channel currents in response to caffeine in wild-type and SM-Ryr2-/- 
VSMCs. 
 
 
 
 
 
 
 
A, Whole-cell outward current in a tibial artery SMC isolated from a wild-type (control) 
mouse. Holding potential was -40 mV. The presence of caffeine is indicated by a horizontal 
line. B, Same protocol as in A, but the VSMC was isolated from a SM-Ryr2-/- mouse. Mean 
values for the evoked currents were larger in control cells (203 ± 41 pA, n = 5 cells out of 3 
mice) compared to SM-Ryr2-/- cells (16 ± 11 pA, n = 11 cells out of 2 mice; p < 0.05). 
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